• Education
    • Higher Education
    • Scholarships & Grants
    • Online Learning
    • School Reforms
    • Research & Innovation
  • Lifestyle
    • Travel
    • Food & Drink
    • Fashion & Beauty
    • Home & Living
    • Relationships & Family
  • Technology & Startups
    • Software & Apps
    • Startup Success Stories
    • Startups & Innovations
    • Tech Regulations
    • Venture Capital
    • Artificial Intelligence
    • Cybersecurity
    • Emerging Technologies
    • Gadgets & Devices
    • Industry Analysis
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy
Today Headline
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
Today Headline
No Result
View All Result
Home Technology & Startups

Better drugs through AI? Insitro CEO on what machine learning can teach Big Pharma

December 2, 2024
in Technology & Startups
Reading Time: 4 mins read
A A
0
1
SHARES
2
VIEWS
Share on FacebookShare on Twitter


WASHINGTON (AP) — Artificial intelligence is changing the way companies do business — helping programmers write code and fielding customer service calls with chatbots.

But the pharmaceutical industry is still waiting to see whether AI can tackle its biggest challenge: finding faster, cheaper ways to develop new drugs.

Despite billions poured into research, new medicines still typically take a decade or more to develop.

Founded in 2018, Insitro is part of a growing field of AI companies promising to accelerate drug discovery by using machine learning to analyze huge datasets of chemical and biological markers. The South San Francisco-based company has signed deals with drugmakers like Eli Lilly and Bristol Myers Squibb to help develop medicines for metabolic diseases, neurological conditions and degenerative disorders.

CEO and founder Daphne Koller spoke with the AP about what AI brings to the challenges of drug discovery. The conversation has been edited for length and clarity.

Q: Why is drug development so difficult?

A: I think the problem with drug discovery is that we are trying to intervene in a system that we only slightly understand. Many of the successes that we’ve seen in the last 15 to 20 years have been when we arrive at a sufficient understanding of the system so we can really design interventions to align with it.

So one of the things that we try to do at Insitro is unravel the underlying complexity of heterogeneous diseases and identify new intervention modes that could help, maybe not the entire population, but perhaps just a subset of it. That way we can really identify the right therapeutic hypothesis to intervene in a particular patient population. And that, I think, is the real crux of the industry’s lack of success.

Q: Companies like Eli Lilly employ thousands of medical scientists and researchers. What can your technology do that those experts can’t?

A: One of the things that has been happening in parallel to the AI revolution is a much quieter revolution in what I call quantitative biology, which is the ability to measure biological systems with unprecedented fidelity. You can measure systems like proteins and cells with increasingly better measurements and technology.

But if you give that data to a person, their eyes will just glaze over because there’s only so many cells someone can look at and only so many subtleties they can see in these images. People are just limited in their ability to perceive subtle differences.

So you end up with a very reductionist view of a very complex, multifaceted system which is really important to unraveling the distinctions between patients and uncovering where an intervention really can make a difference.

Q: How did you become interested in this field?

A: My PhD was in computer science. But I started to get into the field of machine learning in the service of biomedical problems back in 1998 or 1999.

At that time, the problems that machine learning was able to tackle were, frankly, uninspiring. How inspired can you get about classifying spam versus non-spam in a dataset of email messages?

I was looking for something that had more richness to it. And my first foray into this field was not because I was particularly interested in becoming a biologist, but because I was looking for more technically challenging questions. And then, as I started looking into it, I became interested in biology in its own right.

Q: Insitro employs both computer scientists and medical researchers. Was there any culture clash in getting those two groups to work together?

A: This is probably one of the most important things we’ve achieved as an organization.

You can take the most sophisticated, best meaning scientists from either side and put them in the same room together and they might as well be speaking Thai and Swahili to each other.

When you’re an engineer, you’re looking for the strongest, most consistent patterns that are going to allow you to make predictions about a majority of cells or individuals. When you’re a life scientist, oftentimes you’re actually looking for the exceptions because those are the threads that can lead to new discoveries.

So we’ve put in place a number of cultural elements and organizational elements to help people engage with each other openly, constructively and with respect.

Tags: AI revolutionartificial intelligencedrug discoveryEli LillyInsitroMachine Learning
Previous Post

Medicare agents might not recommend the best plans this year as profits take priority todayheadline

Next Post

Oil States Play Spoiler in Failed Plastics Treaty Negotiations

Related Posts

IATA expects sustainable aviation fuel production to double in 2025

June 1, 2025
4

Why AI is primed to be a huge benefit — and a major liability — for consulting’s Big Four

June 1, 2025
5
Next Post

Oil States Play Spoiler in Failed Plastics Treaty Negotiations

  • Trending
  • Comments
  • Latest
Family calls for change after B.C. nurse dies by suicide after attacks on the job

Family calls for change after B.C. nurse dies by suicide after attacks on the job

April 2, 2025
Pioneering 3D printing project shares successes

Product reduces TPH levels to non-hazardous status

November 27, 2024

Hospital Mergers Fail to Deliver Better Care or Lower Costs, Study Finds todayheadline

December 31, 2024

Police ID man who died after Corso Italia fight

December 23, 2024
Harris tells supporters 'never give up' and urges peaceful transfer of power

Harris tells supporters ‘never give up’ and urges peaceful transfer of power

0
Des Moines Man Accused Of Shooting Ex-Girlfriend's Mother

Des Moines Man Accused Of Shooting Ex-Girlfriend’s Mother

0

Trump ‘looks forward’ to White House meeting with Biden

0
Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

0
To tour or not to tour: Artists second-guess going on road as touring gets harder - National

To tour or not to tour: Artists second-guess going on road as touring gets harder – National

June 1, 2025
Egypt Independent

Trump’s foreign policy frustrations are piling up

June 1, 2025
Person sitting at a desk looking at two monitors.

Billionaire David Tepper Bought More Shares of This Artificial Intelligence (AI) Stock That Could Join Apple, Microsoft, and Nvidia in the $3 Trillion Club by 2030 todayheadline

June 1, 2025
Exclusive-Ukraine to set out roadmap for peace at Istanbul talks, document shows

Exclusive-Ukraine to set out roadmap for peace at Istanbul talks, document shows todayheadline

June 1, 2025

Recent News

To tour or not to tour: Artists second-guess going on road as touring gets harder - National

To tour or not to tour: Artists second-guess going on road as touring gets harder – National

June 1, 2025
0
Egypt Independent

Trump’s foreign policy frustrations are piling up

June 1, 2025
1
Person sitting at a desk looking at two monitors.

Billionaire David Tepper Bought More Shares of This Artificial Intelligence (AI) Stock That Could Join Apple, Microsoft, and Nvidia in the $3 Trillion Club by 2030 todayheadline

June 1, 2025
1
Exclusive-Ukraine to set out roadmap for peace at Istanbul talks, document shows

Exclusive-Ukraine to set out roadmap for peace at Istanbul talks, document shows todayheadline

June 1, 2025
4

TodayHeadline is a dynamic news website dedicated to delivering up-to-date and comprehensive news coverage from around the globe.

Follow Us

Browse by Category

  • Africa
  • Asia
  • Basketball
  • Business & Finance
  • Climate Change
  • Crime & Justice
  • Cybersecurity
  • Economic Policies
  • Elections
  • Entertainment
  • Entrepreneurship
  • Environmental Policies
  • Europe
  • Football
  • Gadgets & Devices
  • Health
  • Medical Research
  • Mental Health
  • Middle East
  • Motorsport
  • Olympics
  • Politics
  • Public Health
  • Relationships & Family
  • Science & Environment
  • Software & Apps
  • Space Exploration
  • Sports
  • Stock Market
  • Technology & Startups
  • Tennis
  • Travel
  • Uncategorized
  • Us & Canada
  • Wildlife & Conservation
  • World News

Recent News

To tour or not to tour: Artists second-guess going on road as touring gets harder - National

To tour or not to tour: Artists second-guess going on road as touring gets harder – National

June 1, 2025
Egypt Independent

Trump’s foreign policy frustrations are piling up

June 1, 2025
  • Education
  • Lifestyle
  • Technology & Startups
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy

© 2024 Todayheadline.co

Welcome Back!

OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Business & Finance
  • Corporate News
  • Economic Policies
  • Entrepreneurship
  • Market Trends
  • Crime & Justice
  • Court Cases
  • Criminal Investigations
  • Cybercrime
  • Legal Reforms
  • Policing
  • Education
  • Higher Education
  • Online Learning
  • Entertainment
  • Awards & Festivals
  • Celebrity News
  • Movies
  • Music
  • Health
  • Fitness & Nutrition
  • Medical Breakthroughs
  • Mental Health
  • Pandemic Updates
  • Lifestyle
  • Fashion & Beauty
  • Food & Drink
  • Home & Living
  • Politics
  • Elections
  • Government Policies
  • International Relations
  • Legislative News
  • Political Parties
  • Africa
  • Asia
  • Europe
  • Middle East
  • Artificial Intelligence
  • Cybersecurity
  • Emerging Technologies
  • Gadgets & Devices
  • Industry Analysis
  • Basketball
  • Football
  • Motorsport
  • Olympics
  • Climate Change
  • Environmental Policies
  • Medical Research
  • Science & Environment
  • Space Exploration
  • Wildlife & Conservation
  • Sports
  • Tennis
  • Technology & Startups
  • Software & Apps
  • Startup Success Stories
  • Startups & Innovations
  • Tech Regulations
  • Venture Capital
  • Uncategorized
  • World News
  • Us & Canada
  • Public Health
  • Relationships & Family
  • Travel
  • Research & Innovation
  • Scholarships & Grants
  • School Reforms
  • Stock Market
  • TV & Streaming
  • Advertise with Us
  • Privacy & Policy
  • About us
  • Contact

© 2024 Todayheadline.co